Ipilimumab: controversies in its development, utility and autoimmune adverse events
Year: 2009
Type: article
Source: Cancer Immunology Immunotherapy
Author: Jeffrey Weber
Institutions: University of South Florida, Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Pfizer, National Cancer Institute
OpenAlex ID: W2148576689
